AF
BSX icon

Align Financial’s Boston Scientific BSX Stock Holding History

Align Financial’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.1K Hold
143
– – ﹤0.01% 285
2026
Q1 		$8.97K Sell
143
-12,348
-99% -$988K 0.01% 274
2025
Q4 		$12.5K Buy
+12,491
New +$1.22M 0.01% 259

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Align Financial's BSX Position: Q2 2026 in Review

Align Financial held its Boston Scientific (BSX) position steady in Q2 2026 at 143 shares worth $6.1K. The position accounts for ﹤0.01% of the portfolio, ranked #285.

Align Financial first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.5K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Align Financial held 143 shares of Boston Scientific worth $6.1K as of Q2 2026.
  • Align Financial left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Align Financial's portfolio in Q2 2026, its #285 holding.
  • Align Financial first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Align Financial's Boston Scientific position peaked at $12.5K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Align Financial's 13F filing for Q2 2026, filed 27 Jul 2026.